Perspectives in cancer chemoprevention.
Open Access
- 1 June 1997
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 105 (suppl 4) , 945-954
- https://doi.org/10.1289/ehp.97105s4945
Abstract
Cancer chemoprevention can be defined as prevention of cancer by the administration of one or more chemical entities, either as individual drugs or as naturally occurring constituents of the diet. Based largely on the time period that chemopreventive agents exhibit activity in animal models of carcinogenesis, they can be classified as inhibitors of carcinogen formation, blocking agents, and suppressing agents. The majority of compounds that inhibit the formation of carcinogens prevent the formation of nitrosamines from secondary amines and nitrite in an acidic environment. Blocking agents are inhibitors of tumor initiation, while suppressing agents are inhibitors of tumor promotion/progression. Many well-characterized chemopreventive agents act at one or more steps in both tumor initiation and promotion/progression. The objective of this paper is to provide a general discussion of the mechanisms through which chemopreventive agents inhibit carcinogenesis. Examples of agents that act through these mechanisms are given; however, a complete listing of effective chemopreventive agents is not possible within the context of this paper. At the conclusion is a brief discussion of future prospects in cancer chemoprevention and obstacles to overcome.Keywords
This publication has 143 references indexed in Scilit:
- Screening for chemopreventive (anticarcinogenic) compounds in rodentsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Tamoxifen reduces serum insulin-like growth factor I (IGF-I)Breast Cancer Research and Treatment, 1992
- The effects of ellagic acid and 13-cis-retinoic acid on N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in ratsCancer Letters, 1991
- Organosulfur compounds of garlic modulate mutagenesis, metabolism, and DNA binding of aflatoxin B1Nutrition and Cancer, 1991
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences, 1988
- Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the ratToxicology and Applied Pharmacology, 1988
- Induction by butylated hydroxyanisole of specific molecular forms of glutathione S-transferase and UDP-glucuronyltransferase and inhibition of development of γ-glutamyl transpeptidase-positive foci in rat liverCarcinogenesis: Integrative Cancer Research, 1984
- 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochemical and Biophysical Research Communications, 1981
- Free radicals and singlet oxygen scavengers: Reaction of a peroxy-radical with β-carotene, diphenyl furan and 1,4-diazobicyclo(2,2,2)-octaneBiochemical and Biophysical Research Communications, 1981